Dr. Thomas Diflo is a cum laude graduate of Harvard College and Boston University School of Medicine. He did his general surgery training at Boston University and both his laboratory and clinical Transplant Fellowships at Harvard Medical School, at the New England Deaconess Hospital. He is board-certified in both General Surgery and Surgical Critical Care.
Dr. Diflo went to NYU in 1992 at the completion of his training and was an Associate Professor of Surgery in the Organ Transplant division there. In 2012, he moved to Westchester Medical Center, where he is Chief of the Intra-abdominal Organ Transplant section, and Professor of Surgery at New York Medical College. He has performed over 1000 kidney and liver transplants, and his scientific interests include the mechanisms of chronic rejection, and the pharmacokinetics and mechanisms of action of various immunosuppressant medications. He is currently the PI for two funded studies of cell-free DNA in kidney transplantation. He has been a reviewer with the Agency for Healthcare Research and Quality (AHRQ) study section on Healthcare Safety and Quality Improvement Research (HSQR) for more than a decade.
Since 2001 he has become a widely recognized expert on the international trade in transplanted organs, with a particular interest in the transplantation of the organs of executed prisoners in China. He has given numerous lectures and served on several panels regarding this topic, including testimony before the United States House of Representatives. He has also been a guest on several media programs, including The People’s Pharmacy on National Public Radio, and Anderson Cooper 360 on CNN.